MEDVi partners with OpenLoop Health, a network of licensed clinicians, to determine your eligibility and provide treatments when appropriate
For Noom, GLP-1 therapy is a , temporarily altering appetite and food noise, opening a window to build durable skills and routines, leading to mastery experiences which drive more action
Eligibility for our compounded GLP-1 program is based on BMI and clinical criteria reviewed by a licensed provider
Zepbound is administered as a once-weekly subcutaneous injection, with dosing typically starting at 2.5 mg for 4 weeks, then increasing by 2.5 mg every 4 weeks until reaching the target maintenance dose (5 mg, 10 mg, or 15 mg weekly)
Sun J, Zhang W (2022) Supplementation with dietary omega-3 PUFA mitigates fetal brain inflammation and mitochondrial damage caused by high doses of sodium nitrite in maternal rats